A study to compare the effects of shock wave therapy and ultrasound therapy with soft tissue massage tools in people with heel pain (plantar fasciitis) in rural areas.

Efficacy of Extracorporeal Shock Wave Therapy Versus Ultrasound Therapy Combined With Instrument-Assisted Soft Tissue Mobilization in the Management of Plantar Fasciitis in a Rural Setting: A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088248

Enrollment

Registered

2025-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

Intervention1: Extracorporeal Shock Wave Therapy (ESWT) combined with Instrument Assisted Soft Tissue Mobilization (IASTM): Frequency: three session per week for 2 weeks Energy Density: 0.12 0.28 mJ

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18-45 Both male and female Patients with unilateral plantar fasciitis Clinical diagnosis of plantar fasciitis confirmed by orthopedician. Heel pain lasting from more than three months. Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: Previous foot surgery on the affected side. Patients with bilateral plantar fasciitis Neuropathic or systemic inflammatory diseases. Pregnant or lactating women. Contraindications to ESWT or ultrasound

Design outcomes

Primary

Measure	Time frame
Pain intensity, Pain pressure threshold, Functional disabilityTimepoint: Baseline,After Completion of two week treatment and a two week follow up	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactGAURAV SHAKYA

Faculty of Paramedical Sciences, Uttar Pradesh University of Medical Sciences

Chaudhary.ranjeet@rediffmail.com9760690454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026